A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

NCT06785454 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea
Hypertension

Interventions

DRUG: Lorundrostat
DRUG: Placebo

Sponsor

Mineralys Therapeutics Inc.